JANE STREET GROUP, LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,800,699
-68.1%
252,999
-53.3%
0.00%
-66.7%
Q2 2023$8,786,955
+47.6%
542,070
+51.6%
0.00%
+50.0%
Q1 2023$5,954,789
+995.7%
357,645
+518.6%
0.00%
Q4 2022$543,461
+1409.6%
57,815
+347.9%
0.00%
Q3 2022$36,000
-56.6%
12,907
-54.9%
0.00%
Q2 2022$83,000
-32.5%
28,641
-29.9%
0.00%
Q1 2022$123,000
-61.7%
40,858
-41.5%
0.00%
Q4 2021$321,000
-55.5%
69,833
-39.2%
0.00%
Q3 2021$722,000
-4.6%
114,937
-9.0%
0.00%
Q2 2021$757,000
-48.3%
126,300
-45.5%
0.00%
Q1 2021$1,464,000
+109.7%
231,541
+86.9%
0.00%
Q4 2020$698,000
-43.9%
123,858
-42.1%
0.00%
-100.0%
Q3 2020$1,244,000
-52.0%
213,791
-40.5%
0.00%
-50.0%
Q2 2020$2,591,000
+1833.6%
359,388
+1154.2%
0.00%
Q1 2020$134,000
+44.1%
28,655
+146.3%
0.00%
Q4 2019$93,000
-43.3%
11,633
-51.1%
0.00%
Q3 2019$164,000
-16.3%
23,811
+1.2%
0.00%
Q2 2019$196,000
-90.9%
23,525
-89.2%
0.00%
-100.0%
Q1 2019$2,158,000
+1358.1%
217,087
+1019.0%
0.00%
Q4 2018$148,000
-95.4%
19,400
-89.4%
0.00%
-100.0%
Q3 2018$3,198,000183,5650.01%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders